Skip to main content
REAX
NASDAQ Real Estate & Construction

Real REMAX Group Posts First Combined Quarter: Revenue +28%, 2027 EBITDA Outlook $175-190M

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Real Estate Services Stocks · Real Estate
Sentiment info
Neutral
Importance info
8
Price
$15.8
Mkt Cap
$621.214M
52W Low
$13.25
52W High
$45
52W Position info
19% above low
Off High info
65% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

REAX sits 19% above its 52-week low of $13.25.

Summary

Real REMAX Group's first combined quarter showed revenue up 28% to $727.9M and Adjusted EBITDA up 66% to $33.8M, alongside a $67.2M GAAP net loss from deal costs. Management guided 2027 Adjusted EBITDA to $175-190M while flagging post-quarter agent attrition.


Key Events · Earnings and Guidance · REAX

  • First Combined Quarter Reported

    Q3 2026 revenue of $727.9M, up 28% from $568.5M a year earlier, including REMAX operations from August 25, 2026. Pro forma combined revenue rose 20% to $770.0M.

  • GAAP Loss on Deal Costs

    GAAP net loss of $67.2M, or $2.25 per diluted share, versus a $0.3M loss a year ago, reflecting $52.3M of acquisition-related expenses and $26.4M of accelerated stock-based compensation from merger-related terminations.

  • Adjusted EBITDA Up 66%

    Adjusted EBITDA reached $33.8M from $20.4M, a 4.6% margin versus 3.6%. Management has actioned more than $40M of annualized gross cost savings in two months, including about $28M benefiting Adjusted EBITDA.

  • 2027 Outlook Introduced

    Guidance calls for 2027 revenue of $2.6-2.8B and Adjusted EBITDA of $175-190M, and Q4 2026 revenue of $575-625M with Adjusted EBITDA of $32-38M, assuming a 5-10% decline in U.S. existing-home sales.


Analysis · REAX · Real Estate & Construction

The first look at the merged Real/REMAX platform cuts both ways. Revenue rose 28% to $727.9M and Adjusted EBITDA jumped 66% to $33.8M, with more than $40M of annualized cost savings already actioned in two months — faster than management had guided. The GAAP picture, however, is ugly: a $67.2M net loss driven by $52.3M of acquisition costs and $26.4M of accelerated stock compensation. Management also disclosed that Real's agent count has already slipped to about 36,200 from 36,610 at quarter-end, with more than 500 agents offboarded for unpaid dues or expired licenses. The 2027 outlook of $175-190M Adjusted EBITDA is the number that will set expectations for the combined company, and it assumes a further 5-10% decline in U.S. existing-home sales and a 3-4% drop in home prices — so the earnings growth is coming from cost cuts and REMAX contribution, not market recovery. Leverage is the constraint: $525M of term loan outstanding after a voluntary $25M paydown, with a sub-2.0x net leverage target by end-2028.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, REAX was trading at $15.80 on NASDAQ in the Real Estate & Construction sector, with a market capitalization of approximately $621.2M. The 52-week trading range was $13.25 to $45.00. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

REAX - Latest Insights

REAX
Nov 05, 2026, 2:20 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $15.37
Real-time Price: $8.44 info
Change: -$6.93 (-45%) info
Market Cap: $313.35M info
REAX
Nov 05, 2026, 7:15 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $16.31
Real-time Price: $8.44 info
Change: -$7.87 (-48%) info
Market Cap: $313.35M info
REAX
Nov 05, 2026, 7:06 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $16.31
Real-time Price: $8.44 info
Change: -$7.87 (-48%) info
Market Cap: $313.35M info
REAX
Nov 03, 2026, 4:05 PM EST
Filing Type: 8-K12B/A
Importance Score:
7
Price at Filing: $15.23
Real-time Price: $8.44 info
Change: -$6.79 (-45%) info
Market Cap: $313.35M info
REAX
Aug 24, 2026, 4:47 PM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $2.65
Real-time Price: $8.44 info
Change: Reverse Stock Split info
Market Cap: $313.35M info